Aqueous estrogens in the management of respiratory distress syndrome.
D000818:Animals; D001034:Apgar Score; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D004357:Drug Synergism; D004967:Estrogens / Q000008:administration & dosage* / Q000633:toxicity; D004966:Estrogens, Conjugated (USP) / Q000008:administration & dosage* / Q000633:toxicity; D004970:Estrone / Q000633:toxicity; D005260:Female; D006801:Humans; D006819:Hyaline Membrane Disease / Q000188:drug therapy* / Q000401:mortality; D007231:Infant, Newborn; D007273:Injections, Intramuscular; D008297:Male; D008722:Methods; D010102:Oxygen Inhalation Therapy; D010808:Physical Examination; D010919:Placebos; D011247:Pregnancy; D011817:Rabbits; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy* / Q000401:mortality; D012737:Sex Factors; D013535:Suspensions; D014628:Vagotomy
D004967:Estrogens; D004966:Estrogens, Conjugated (USP); D010919:Placebos; D013535:Suspensions; D004970:Estrone